| Nuviva Medical Weight Loss Clinics
Connell E, Le Gall G, Pontifex MG, et al
Published in WholeFoods Magazine, October 2015
A comparison of baseline demographics and clinical characteristics between GLP-1RAs and second- or third-line glucose-lowering medications is presented in ESM Tables 4 and 5
(2021) Cell Rep 36 : 109374-109374 PubMed: 34260945 Search on PubMed DOI: Primary Citation Related Structures: 7KI0, 7KI1 PubMed Abstract: The glucagon-like peptide-1 receptor (GLP-1R) regulates insulin secretion, carbohydrate metabolism, and appetite and is an important target for treatment of type 2 diabetes and obesity
Speak to your GP if you experience persistent changes in sexual desire, new erectile dysfunction, or severe medication side effects